Ezetrol Post-Marketing Study
NCT00753883 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2008-09-17
Summary
To compare the lipid lowering efficacy of adding ezetimibe to statin vs. statin alone.
Conditions
Interventions
- DRUG
-
simvastatin
simvastatin 20 mg/QD for 6 Weeks.
- DRUG
-
Ezetimibe
Ezetimibe 10 mg/QD for 8 weeks.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2008-05-31
More Related Trials
-
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
NCT00328523 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1)
NCT01381679 ·Status: COMPLETED
-
Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults
NCT00099684 ·Status: COMPLETED ·Phase: NA
-
SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
NCT00045812 ·Status: COMPLETED ·Phase: PHASE2
-
Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
NCT00099996 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)
NCT00129402 ·Status: COMPLETED ·Phase: PHASE3
-
Eze/Simva Switch Study in Diabetics (0653A-807)
NCT00541697 ·Status: COMPLETED ·Phase: PHASE3
-
The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study
NCT00817843 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
NCT05681247 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
NCT00621101 ·Status: COMPLETED ·Phase: PHASE1
-
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
NCT00861731 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study
NCT01849068 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
NCT00621699 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)
NCT06655311 ·Status: COMPLETED ·Phase: PHASE1
-
Physiological Study of Human Cholesterol Metabolism and Excretion
NCT01603758 ·Status: COMPLETED ·Phase: PHASE1
-
MD Ezetimibe Cyclosporine Interaction (0653-057)
NCT00653276 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
NCT01836198 ·Status: COMPLETED ·Phase: PHASE1
-
Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe
NCT01424891 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects
NCT06547359 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects
NCT00987558 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
NCT00810303 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
NCT00653913 ·Status: COMPLETED ·Phase: PHASE1
-
Ezetimibe for Patients With Chronic Hepatitis D
NCT03099278 ·Status: UNKNOWN ·Phase: PHASE2
-
The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients
NCT02103049 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
NCT03399786 ·Status: COMPLETED ·Phase: PHASE3